Cargando…
One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
The filamentous fungus Ashbya gossypii is currently used for the industrial production of vitamin B2. Furthermore, the ability of A. gossypii to grow using low‐cost substrates together with the inexpensive downstream processing makes this fungus an attractive biotechnological chassis. Indeed, the pr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801137/ https://www.ncbi.nlm.nih.gov/pubmed/31055883 http://dx.doi.org/10.1111/1751-7915.13425 |
_version_ | 1783460518243074048 |
---|---|
author | Jiménez, Alberto Muñoz‐Fernández, Gloria Ledesma‐Amaro, Rodrigo Buey, Rubén M. Revuelta, José L. |
author_facet | Jiménez, Alberto Muñoz‐Fernández, Gloria Ledesma‐Amaro, Rodrigo Buey, Rubén M. Revuelta, José L. |
author_sort | Jiménez, Alberto |
collection | PubMed |
description | The filamentous fungus Ashbya gossypii is currently used for the industrial production of vitamin B2. Furthermore, the ability of A. gossypii to grow using low‐cost substrates together with the inexpensive downstream processing makes this fungus an attractive biotechnological chassis. Indeed, the production in A. gossypii of other high‐added value compounds such as folic acid, nucleosides and biolipids has been described. Hence, the development of new methods to expand the molecular toolkit for A. gossypii genomic manipulation constitutes an important issue for the biotechnology of this fungus. In this work, we present a one‐vector CRISPR/Cas9 system for genomic engineering of A. gossypii. We demonstrate the efficiency of the system as a marker‐less approach for nucleotide deletions and substitutions both with visible and invisible phenotypes. Particularly, the system has been validated for three types of genomic editions: gene inactivation, the genomic erasure of loxP scars and the introduction of point mutations. We anticipate that the use of the CRISPR/Cas9 system for A. gossypii will largely contribute to facilitate the genomic manipulations of this industrial fungus in a marker‐less manner. |
format | Online Article Text |
id | pubmed-6801137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68011372019-10-22 One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii Jiménez, Alberto Muñoz‐Fernández, Gloria Ledesma‐Amaro, Rodrigo Buey, Rubén M. Revuelta, José L. Microb Biotechnol Brief Reports The filamentous fungus Ashbya gossypii is currently used for the industrial production of vitamin B2. Furthermore, the ability of A. gossypii to grow using low‐cost substrates together with the inexpensive downstream processing makes this fungus an attractive biotechnological chassis. Indeed, the production in A. gossypii of other high‐added value compounds such as folic acid, nucleosides and biolipids has been described. Hence, the development of new methods to expand the molecular toolkit for A. gossypii genomic manipulation constitutes an important issue for the biotechnology of this fungus. In this work, we present a one‐vector CRISPR/Cas9 system for genomic engineering of A. gossypii. We demonstrate the efficiency of the system as a marker‐less approach for nucleotide deletions and substitutions both with visible and invisible phenotypes. Particularly, the system has been validated for three types of genomic editions: gene inactivation, the genomic erasure of loxP scars and the introduction of point mutations. We anticipate that the use of the CRISPR/Cas9 system for A. gossypii will largely contribute to facilitate the genomic manipulations of this industrial fungus in a marker‐less manner. John Wiley and Sons Inc. 2019-05-05 /pmc/articles/PMC6801137/ /pubmed/31055883 http://dx.doi.org/10.1111/1751-7915.13425 Text en © 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Brief Reports Jiménez, Alberto Muñoz‐Fernández, Gloria Ledesma‐Amaro, Rodrigo Buey, Rubén M. Revuelta, José L. One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii |
title | One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
|
title_full | One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
|
title_fullStr | One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
|
title_full_unstemmed | One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
|
title_short | One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
|
title_sort | one‐vector crispr/cas9 genome engineering of the industrial fungus ashbya gossypii |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801137/ https://www.ncbi.nlm.nih.gov/pubmed/31055883 http://dx.doi.org/10.1111/1751-7915.13425 |
work_keys_str_mv | AT jimenezalberto onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii AT munozfernandezgloria onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii AT ledesmaamarorodrigo onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii AT bueyrubenm onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii AT revueltajosel onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii |